Novo Nordisk A/S (NVO)
45.33
0.00 (0.00%)
USD |
NYSE |
Sep 01, 12:17
Novo Nordisk Cash from Operations (Annual) : 18.01B for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 18.01B |
| December 31, 2024 | 17.54B |
| December 31, 2023 | 15.80B |
| December 31, 2022 | 11.14B |
| December 31, 2021 | 8.742B |
| December 31, 2020 | 7.947B |
| December 31, 2019 | 7.016B |
| December 31, 2018 | 7.065B |
| December 31, 2017 | 6.246B |
| December 31, 2016 | 7.182B |
| December 31, 2015 | 5.692B |
| December 31, 2014 | 5.639B |
| December 31, 2013 | 4.618B |
| December 31, 2012 | 3.833B |
| December 31, 2011 | 3.990B |
| December 31, 2010 | 3.498B |
| December 31, 2009 | 2.875B |
| December 31, 2008 | 2.558B |
| December 31, 2007 | 2.105B |
| Date | Value |
|---|---|
| December 31, 2006 | 1.302B |
| December 31, 2005 | 1.452B |
| December 31, 2004 | 1.267B |
| December 31, 2003 | 936.74M |
| December 31, 2002 | 619.40M |
| December 31, 2001 | 518.58M |
| December 31, 2000 | 649.61M |
| December 31, 1999 | 518.49M |
| December 31, 1998 | 518.92M |
| December 31, 1997 | 457.50M |
| December 31, 1996 | 330.82M |
| December 31, 1995 | 452.11M |
| December 31, 1994 | 341.63M |
| December 31, 1993 | 294.01M |
| December 31, 1992 | 220.78M |
| December 31, 1991 | 185.05M |
| December 31, 1990 | 243.33M |
| December 31, 1989 | 135.33M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| AstraZeneca PLC | 14.90B |
| Johnson & Johnson | 24.53B |
| Eli Lilly & Co. | 16.81B |
| Merck & Co., Inc. | 16.47B |
| Novartis AG | 19.24B |